These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 217544

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.
    Hoffman GJ, Lazarowitz SG, Hayward SD.
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2979-83. PubMed ID: 6248876
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
    Edson CM, Thorley-Lawson DA.
    J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807
    [Abstract] [Full Text] [Related]

  • 5. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
    Qualtiere LF, Chase R, Vroman B, Pearson GR.
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T, Bertoni G, Medveczky MM, Medveczky PG, Nguyen QV, Humphreys RE.
    J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
    Mueller-Lantzsch N, Georg-Fries B, Herbst H, zur Hausen H, Braun DG.
    Int J Cancer; 1981 Sep 15; 28(3):321-7. PubMed ID: 6172392
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification and characterization of Epstein-Barr virus-related surface polypeptides expressed on n-butyrate-treated P3HR-1 cells.
    Kawanishi M, Sugawara K, Ito Y.
    Intervirology; 1983 Sep 15; 19(3):162-8. PubMed ID: 6299996
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.
    Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB.
    J Gen Virol; 1987 Jun 15; 68 ( Pt 6)():1575-86. PubMed ID: 2438376
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC, Klein G.
    J Virol; 1976 Apr 15; 18(1):151-5. PubMed ID: 176457
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
    Takada K, Fujiwara S, Yano S, Osato T.
    Med Microbiol Immunol; 1983 Apr 15; 171(4):225-31. PubMed ID: 6304479
    [Abstract] [Full Text] [Related]

  • 17. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants.
    Dölken G, Klein G.
    J Natl Cancer Inst; 1977 May 15; 58(5):1239-45. PubMed ID: 192896
    [Abstract] [Full Text] [Related]

  • 18. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
    Qualtiere LF, Pearson GR.
    Virology; 1980 Apr 30; 102(2):360-9. PubMed ID: 6245514
    [No Abstract] [Full Text] [Related]

  • 19. Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides.
    North JR, Morgan AJ, Epstein MA.
    Int J Cancer; 1980 Aug 30; 26(2):231-40. PubMed ID: 6162806
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K, Hinuma Y.
    J Immunol; 1978 May 30; 120(5):1702-8. PubMed ID: 207776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.